TSX:MDA.TO News 19 January 2026

Morgan Stanley Upgrade Lifts MDA Space as 2026 Space-Tech Funding Forecast Rises

Private investment in space technology jumped 48% to $12.4 billion in 2025, Seraphim Space said, with further gains expected in 2026. MDA Space shares surged 14.5% after a Morgan Stanley upgrade, while Rocket Lab’s price target was raised to $105. Canadian stocks slipped 0.1% after U.S. tariff threats. MDA recently secured a U.S. Missile Defense Agency contract for its SHIELD program.

19 January 2026

Financial Forecasts·NASDAQ:ASTS·NASDAQ:LUNR·NASDAQ:RKLB·TSX:MDA.TO

Lumentum stock hits a record close — Citi raises target, insider filing lands ahead of Monday

7 February 2026

Lumentum shares jumped 9.3% to a record $551.99 Friday after Citigroup and JPMorgan raised price targets to $560 and $565. The surge followed strong quarterly results and guidance, plus a director’s filing to sell up to 4,849 shares. Markets reopen Monday ahead of the company’s March 17 investor briefing at OFC.

Nvidia stock price rebounds nearly 8% as AI spending race heats up — what to watch next week

7 February 2026

Nvidia shares jumped 7.9% to $185.41 Friday, their strongest gain in weeks, as chip stocks rallied on news of major AI infrastructure spending by Amazon and Alphabet. The PHLX semiconductor index rose 5.7%. Investors now await U.S. inflation data on Feb. 13 and Nvidia’s earnings report on Feb. 25.

Lucid stock jumps 14% as Dow tops 50,000 — what LCID investors watch next week

7 February 2026

Lucid Group shares jumped 14% to $10.86 at Friday’s close, recovering from an 8% drop the previous day. The move followed a broad Wall Street rally that lifted high-volatility stocks. Lucid reported fourth-quarter deliveries of 5,345 vehicles and full-year deliveries of 15,841. Investors await Lucid’s Feb. 24 results for updates on cash and demand.

Pfizer stock price rises into weekend as FDA priority review, TrumpRx discounts grab focus

7 February 2026

Pfizer shares rose 2.8% to $27.22 Friday after the FDA granted priority review for a Hympavzi label expansion, with a decision expected in Q2 2026. Trading volume reached 50.7 million shares. The TrumpRx.gov drug-discount rollout put renewed focus on pricing, with over 30 Pfizer drugs listed at launch.

TSX:MDA.TO News 19 January 2026

Morgan Stanley Upgrade Lifts MDA Space as 2026 Space-Tech Funding Forecast Rises

Stock Market Today

Lumentum stock hits a record close — Citi raises target, insider filing lands ahead of Monday

Nvidia stock price rebounds nearly 8% as AI spending race heats up — what to watch next week

Lucid stock jumps 14% as Dow tops 50,000 — what LCID investors watch next week

Pfizer stock price rises into weekend as FDA priority review, TrumpRx discounts grab focus